Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Income Quality Over TimeStable
Percentile Rank14
3Y CAGR-7.5%
5Y CAGR-7.1%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-7.5%/yr
vs -1.7%/yr prior
5Y CAGR
-7.1%/yr
Consistent
Acceleration
-5.8pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
20250.67-6.6%
20240.72-19.9%
20230.89+5.9%
20220.84-19.9%
20211.05+9.0%
20200.96+20.7%
20190.80-11.5%
20180.90+17.6%
20170.77+7.9%
20160.71-